medigraphic.com
Colegio de Medicina Interna de México.

2016, Number 1

<< Back Next >>

Med Int Mex 2016; 32 (1)

Normocalcemic primary hyperparathyroidism

Jiménez-Sánchez JA, Izaguirre-Gutiérrez VF, Casillas-Becerril MA, Aguirre-Domínguez JA, Cepeda- Jiménez M

Language: Spanish
References: 19
Page: 146-151
PDF size: 996.72 Kb.


ABSTRACT

We report the case of a patient with weakness, fatigue, anxiety; a history of kidney stones that required nephrectomy; he also had recurrent urinary tract infections and referred prior pancreatitis. Patient assisted to the medical service for recurrent infections, therefore study protocol began to rule out underlying diseases, being among the most common kidney stones that the patient had and nephrocalcinosis, so study was initiated to rule out primary hyperparathyroidism although hypercalcemia was not found, patient had always a normocalcemic course, finding high levels of parathyroid hormone and normal vitamin D levels, discarding other causes of secondary hyperparathyroidism.


REFERENCES

  1. Marocci C, Cetain F. Primary hyperparathyroidism. N Engl J Med 2011;365:2389-2397.

  2. Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 2011;96:2377-2385.

  3. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 2009;94:351-365.

  4. Silverberg SJ, Bilezikian JP. “Incipient” primary hyperparathyroidism: a “forme fruste” of an old disease. J Clin Endocrinol Metab 2003;88:5348-5352.

  5. Díaz Soto G, Julián MT, Puig-Domingo M, et al. Normocalcemic primary hyperparathyroism: a newly emerging disease needing therapeutic intervention. Hormones 2012;11:390-396.

  6. Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335-339.

  7. Lundgren E, Hagström EG, Lundin J, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population based screening 8 years ago. World J Surg 2002;26:931-936.

  8. Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol 2010;54:106-109.

  9. Maruani G, Hertig A, Paillard M, Houillier P. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 2003;88:4641-4648.

  10. Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom 2013;16:33-39.

  11. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): Institute of Medicine,2011; National Academies Press (US).

  12. Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997;29:496-502.

  13. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 1988;67:1294-1298.

  14. Gallagher JC, Nordin BE. Treatment with with oestrogens of primary hyperparathyroidism in postmenopausal women. Lancet 1972;1:503-507.

  15. Selby PL, Peacock M. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med 1986;314:1481-1485.

  16. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, et al. Normocalcemic primary hyperparathyroidism: further characterizaction of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3001-3005.

  17. Hagström E, Lundgren E, Rastad J, et al. Metabolic abnormalities in patients with normoclcemic hyperparathyroidism detected at a population-based screening. Eur J Endocrinol 2006;155:33-39.

  18. Calvi LM, Bushinsky DA. When is it appropriate to order an ionized calcium? J Am Soc Nephrol 2008;19:1257-1260.

  19. Cusano NE, Silverberg SJ, Bilezikian JP. Normocalcemic primary hyperparathyroidism. J Clin Densitom 2013;16:33-39.




2020     |     www.medigraphic.com